Tables
- TABLE 1
Health costs and income in euros before and after a diagnosis of idiopathic pulmonary fibrosis (IPF) diagnosis
Before After IPF Control p-value IPF Control p-value Inpatient treatment 1040±3785 904±3740 0.970 14 683±18 440 1528±5500 <0.0001 Outpatient treatment 266±567 223±1198 0.302 1198±3314 426±1673 <0.0001 Medication 481±630 391±700 0.001 1151±1300 534±830 <0.0001 National Health Insurance 243±231 246±339 1.0 464±476 325±372 <0.0001 Direct costs# 2030 1764 17 495 2813 Employment income 13 603±23 852 15 558±24 684 0.280 5164±15 506 10 841±20 854 <0.0001 Indirect costs¶ 1955 5677 Public transfer payments+ 10 726 10 194 12 478 11 653 Total costs§ 3985 1764 23 173 2813 Net costsƒ 2753 21 184 Data are presented as mean±sd or mean value per individual, unless otherwise stated. #: the sum of inpatient treatment, outpatient treatment, medication and national health insurance; ¶: the difference in employment income between cases and controls; +: the sum of pensions, other public transfer payments and publicly funded sickness benefits; §: sum of direct and indirect costs; ƒ: the difference between direct costs, indirect costs and public transfer payments.
Vol 4 Issue 2
Table of Contents
Economic consequences of idiopathic pulmonary fibrosis in Denmark
